E
Cytek Biosciences, Inc. CTKB
$4.10 -$0.07-1.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -2.18% -7.59% -1.30% 7.29% -6.19%
Total Other Revenue -- -- -- -- --
Total Revenue -2.18% -7.59% -1.30% 7.29% -6.19%
Cost of Revenue 2.62% -2.50% -5.40% 8.03% -1.63%
Gross Profit -6.17% -12.41% 1.83% 6.72% -9.68%
SG&A Expenses 7.11% 6.08% 5.50% 4.21% -4.74%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 1.96% 1.51% -2.19% 2.44% -6.25%
Operating Income -24.59% -39.51% 381.75% 33.83% 6.57%
Income Before Tax 5.72% -25.28% 151.11% 103.75% -8.96%
Income Tax Expenses -136.70% 104.82% 148.85% -134.52% 247.17%
Earnings from Continuing Operations 46.49% -84.83% 75.23% 114.58% -137.78%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 46.49% -84.83% 75.23% 114.58% -137.78%
EBIT -24.59% -39.51% 381.75% 33.83% 6.57%
EBITDA -29.99% -44.99% 49.93% 48.48% 10.15%
EPS Basic 44.58% -88.54% 81.31% 115.19% -145.82%
Normalized Basic EPS 2.34% -27.97% 94.79% 103.65% -12.87%
EPS Diluted 45.00% -80.00% 73.48% 114.40% -147.68%
Normalized Diluted EPS 2.34% -27.97% 94.79% 103.65% -12.87%
Average Basic Shares Outstanding -3.43% -1.97% -3.34% -3.80% -3.29%
Average Diluted Shares Outstanding -3.43% -1.97% -3.34% -2.49% -3.29%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --